Skip to main content
Year archive

Vicore Pharma Holding — 2024 filings

All 30 regulatory filings released by Vicore Pharma Holding (VICO) in 2024, sourced directly from the official regulator.

30 Filings
2024 Period
2024 filings (30)
Filing Released Lang
Major Shareholding Notification 2024
Major Shareholding Notification
2024-11-08 Swedish
Interim / Quarterly Report 2024
Interim / Quarterly Report Q3 2024
2024-11-05 Swedish
Interim / Quarterly Report 2024
Interim / Quarterly Report Q3 2024
2024-11-05 English
Vicore announces the Nomination Committee for the 2025 Annual General Meeting
Regulatory Filings
2024-11-04 English
Vicore offentliggör valberedningen inför årsstämman 2025
Board/Management Information
2024-11-04 Swedish
Ökning av antalet aktier och röster i Vicore Pharma
Share Issue/Capital Change
2024-10-31 Swedish
Increase in number of shares and votes in Vicore Pharma
Declaration of Voting Results & Voting Rights Announcements
2024-10-31 English
Major Shareholding Notification 2024
Major Shareholding Notification
2024-10-21 Swedish
Vicore Pharma har framgångsrikt genomfört en riktad nyemission om cirka 100 MSEK
Share Issue/Capital Change
2024-10-07 Swedish
Vicore Pharma has successfully carried out a directed share issue of approximately SEK 100 million
Share Issue/Capital Change
2024-10-07 English
Vicore Pharma offentliggör det preliminära utfallet i företrädesemissionen
Capital/Financing Update
2024-10-04 Swedish
Vicore Pharma publishes preliminary outcome in the rights issue
Capital/Financing Update
2024-10-04 English
Major Shareholding Notification 2024
Major Shareholding Notification
2024-09-17 Swedish
Vicore Pharma beslutar om en företrädesemission motsvarande cirka 782 MSEK
Capital/Financing Update
2024-09-10 Swedish
Vicore Pharma announces a rights issue of approximately SEK 782 million
Capital/Financing Update
2024-09-10 English
Interim / Quarterly Report 2024
Interim / Quarterly Report Q2 2024
2024-08-22 Swedish
Interim / Quarterly Report 2024
Interim / Quarterly Report Q2 2024
2024-08-22 English
Ökning av antalet aktier och röster i Vicore Pharma
Share Issue/Capital Change
2024-05-31 Swedish
Increase of number of shares and votes in Vicore Pharma
Share Issue/Capital Change
2024-05-31 English
Bulletin from the annual general meeting of Vicore Pharma Holding AB (publ)
AGM Information
2024-05-07 English
Kommuniké från årsstämma i Vicore Pharma Holding AB (publ)
AGM Information
2024-05-07 Swedish
Interim / Quarterly Report 2024
Interim / Quarterly Report Q1 2024
2024-05-03 Swedish
Interim / Quarterly Report 2024
Interim / Quarterly Report Q1 2024
2024-05-03 English
Kallelse till årsstämma i Vicore Pharma Holding AB (publ)
AGM Information
2024-04-04 Swedish
Notice of annual general meeting of Vicore Pharma Holding AB (publ)
AGM Information
2024-04-04 English
Annual Report (ESEF) 2023
Annual Report (ESEF) FY 2023
2024-03-27 Swedish
Interim / Quarterly Report 2023
Interim / Quarterly Report Q4 2023
2024-02-28 Swedish
Interim / Quarterly Report 2023
Interim / Quarterly Report FY 2023
2024-02-28 English
Vicore och Nippon Shinyaku ingår exklusivt licensavtal för utveckling och kommersialisering av C21 i Japan
Regulatory Filings
2024-02-09 Swedish
Vicore and Nippon Shinyaku Enter into an Exclusive License Agreement to Develop and Commercialize C21 in Japan
Regulatory Filings
2024-02-09 English